Lv4
470 积分 2024-06-26 加入
Asthma–chronic obstructive pulmonary disease overlap in China: prevalence, associated factors and comorbidities in middle-aged and older adults
2天前
已完结
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
11天前
已完结
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
11天前
已完结
Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma
11天前
已完结
Presence of 1q21 gain and amplification may be associated with poorer outcomes in Daratumumab-treated Multiple Myeloma Patients
11天前
已完结
The Role of 1q Abnormalities in Multiple Myeloma: Genomic Insights, Clinical Implications, and Therapeutic Challenges
11天前
已完结
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
11天前
已完结
Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review
15天前
已完结
Tumor Heterogeneity-Driven Individualized Therapy
21天前
已完结
Tumor Heterogeneity-Driven Individualized Therapy
22天前
已关闭
皖公网安备34019202002308
